The NASA Smart Probe employs multiple microsensors, together with fuzzy logic and neural networks, to provide a unique tissue "signature" in real time. We here review the Smart Probe concept and summarize early data from small animal studies on tissue identification. Recent clinical information gathered from women undergoing biopsy for suspected breast cancer by the NASA licensee, BioLuminate Inc., is also presented. The sensors employed in the Smart Probe for breast cancer include electrical impedance and optical spectroscopy (both broadband or white light, and laser light (infrared and blue/fluorescence)). Data are acquired 100 times per second; a typical breast "biopsy" typically generates 500 MB of data. The multiparameter breast cancer probe-one millimeter in diameter-can clearly differentiate normal breast, benign lesions, and breast carcinoma.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.